➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
Moodys

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Exela Pharma Scs Llc Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for EXELA PHARMA SCS LLC, and what generic alternatives to EXELA PHARMA SCS LLC drugs are available?

EXELA PHARMA SCS LLC has ten approved drugs.

There are three US patents protecting EXELA PHARMA SCS LLC drugs.

Summary for Exela Pharma Scs Llc
US Patents:3
Tradenames:10
Ingredients:10
NDAs:10

Drugs and US Patents for Exela Pharma Scs Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Exela Pharma Scs Llc NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;INTRAVENOUS 209387-001 Mar 8, 2017 RX Yes Yes   Start Trial   Start Trial
Exela Pharma Scs Llc SODIUM BICARBONATE sodium bicarbonate INJECTABLE;INJECTION 211091-003 Jun 20, 2019 AP RX No No   Start Trial   Start Trial
Exela Pharma Scs Llc GLYRX-PF glycopyrrolate SOLUTION;INTRAMUSCULAR, INTRAVENOUS 210997-003 Apr 9, 2020 RX No No   Start Trial   Start Trial
Exela Pharma Scs Llc TRANEXAMIC ACID tranexamic acid SOLUTION;INTRAVENOUS 212020-001 Apr 15, 2019 RX Yes Yes   Start Trial   Start Trial
Exela Pharma Scs Llc ELCYS cysteine hydrochloride SOLUTION;INTRAVENOUS 210660-001 Apr 16, 2019 RX Yes Yes 10,583,155   Start Trial Y   Start Trial
Exela Pharma Scs Llc GANZYK-RTU ganciclovir SOLUTION;INTRAVENOUS 209347-001 Feb 17, 2017 RX Yes Yes 9,486,530   Start Trial Y   Start Trial
Exela Pharma Scs Llc GLYRX-PF glycopyrrolate SOLUTION;INTRAMUSCULAR, INTRAVENOUS 210997-001 Jul 11, 2018 RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Moodys
Colorcon
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.